Načítá se...
Pharmacologic Therapies for Idiopathic Pulmonary Fibrosis, Past and Future
Idiopathic pulmonary fibrosis (IPF) is a severe, progressive fibrotic disease of the lung of unknown etiology that affects approximately 150,000 patients in the United States. It carries a median survival of two to three years, but clinical course can vary markedly from patient to patient. There has...
Uloženo v:
| Vydáno v: | Ann Med |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4638420/ https://ncbi.nlm.nih.gov/pubmed/25613169 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/07853890.2014.991751 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|